Home › Overweight › Oklahoma › Tulsa
Overweight clinical trials in Tulsa, OK
6 studies for Overweight are looking for participants at sites in and around Tulsa (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
RecruitingPhase 3
- Central States Research, Tulsa
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
RecruitingPhase 3
- Central States Research, Tulsa
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
RecruitingPhase 3
- Essential Medical Research, Tulsa
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
RecruitingPhase 3
- Delricht Research of Tulsa Clinical Trials, Tulsa
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
RecruitingPhase 3Healthy volunteers welcome
- ACCOMPLISH-2 Research Site, Tulsa
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
RecruitingPhase 3
- Research Site, Tulsa
Overweight trials in other cities
- Houston, TX33 studies
- San Antonio, TX33 studies
- Chicago, IL28 studies
- Orlando, FL25 studies
- Las Vegas, NV23 studies
- Miami, FL23 studies
- Dallas, TX20 studies
- Atlanta, GA20 studies
- Jacksonville, FL19 studies
- Washington, DC19 studies
- New York City, NY19 studies
- Austin, TX18 studies
Other studies in Tulsa
- Heart Failure9 studies
- Melanoma5 studies
- Ischemic Stroke5 studies
- Obesity5 studies
- Aortic Valve Stenosis4 studies
- Depression4 studies
- Endometrial Cancer4 studies
- Cancer (all types)4 studies
- Breast Cancer4 studies
- Parkinson's Disease4 studies
- Ovarian Cancer4 studies
- Non-Small Cell Lung Cancer4 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.